Nasdaq
PPBT
Purple Biotech Ltd.
- Health Care
- Israel
- Listed 2015
- 1 day
- −6.0%
- 1 month
- −11.3%
- 1 year
- −93.4%
$1.41 · Mkt cap $2.29M
At the 6 Aug 2026 close
A foreign company trading in the US through depositary receipts.
Nasdaq
Purple Biotech Ltd.
$1.41 · Mkt cap $2.29M
At the 6 Aug 2026 close
A foreign company trading in the US through depositary receipts.
Purple Biotech Ltd. trades under the ticker PPBT on Nasdaq, in the Health Care sector (Biotechnology: Pharmaceutical Preparations). It has been listed since 2015. Its market capitalisation is $2.29M. The last closing price was $1.41, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is −93.4%, and −11.3% over the past month. Returns are price returns and exclude dividends.
This page exists because PPBT is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.